IDegLira HIGH Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 145 participants.
Also called NCT03737240
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 145 participants
- Sponsor
- Registry
-
NCT03737240
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03737240. Randomized; no masking; primary purpose treatment. Start 2019-01-15 (actual); primary completion 2022-07-08 (actual). Results posted on 2023-09-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- IDegLira HIGH Trial
- Condition
- Diabetes Mellitus
- Intervention (Drug)
- IDegLira
- Intervention (Drug)
- Insulin Degludec (U-100)
- Intervention (Drug)
- Insulin Aspart
- Lead sponsor
- Emory University
- Collaborator
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct03737240- Content hash
9253fdff1b4fc7bfd152bac10928b3fc979107d18445d9041f6b005be2f8a2a4